{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:29:47Z","timestamp":1787678987484,"version":"build-2784847793"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We investigated association between blood pressure and glucose control and the prevalence of albuminuria and left ventricular hypertrophy (LVH) in patients with hypertension and diabetes. Our study participants were treated patients with both diseases, enrolled in a China nationwide registry. The 773 patients were classified into four groups according to the control status of hypertension (systolic\/diastolic blood pressure [BP] \u2264140\/90\u00a0mm\u00a0Hg) and diabetes (HbA1c &lt;7.0%): both uncontrolled (n\u00a0=\u00a0208), only diabetes (n\u00a0=\u00a0175) or hypertension controlled (n\u00a0=\u00a0172), and both controlled (n\u00a0=\u00a0218). Albuminuria was defined as a urinary albumin\u2010to\u2010creatinine ratio of \u226530\u00a0mg\/g. LVH was assessed by the electrocardiogram Cornell product method. Antihypertensive therapy was not different between the four groups (<jats:italic>P<\/jats:italic>\u00a0\u2265\u00a0.48). The use of insulin alone or insulin plus oral antidiabetic agents was significantly higher than those with both diseases controlled (<jats:italic>P<\/jats:italic>\u00a0\u2264\u00a0.02). Patients with controlled hypertension and diabetes had a significantly (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a0.0001) lower prevalence of albuminuria (odds ratio 0.22, 95% confidence interval 0.11\u20100.43) than those with both diseases uncontrolled. Intensive BP control to &lt;130\/80\u00a0mm\u00a0Hg was associated with lower risks of albuminuria in all patients (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.001) and patients with HbA1c &lt;7.0% (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.048). Intensive glycemic control to HbA1c &lt;6.5% was also associated with a significantly lower risk of albuminuria in all patients (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.01), but not those with controlled BP (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.43). Similar trends were observed for LVH, but statistical significance was not achieved on either intensive control condition (<jats:italic>P<\/jats:italic>\u00a0\u2265\u00a0.07). In patients with hypertension and diabetes, blood pressure and glucose control were associated with a lower prevalence of albuminuria and LVH, especially when achieving a more stringent target.<\/jats:p>","DOI":"10.1111\/jch.13793","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T18:29:48Z","timestamp":1579112988000},"page":"212-220","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Blood pressure and glucose control and the prevalence of albuminuria and left ventricular hypertrophy in patients with hypertension and diabetes"],"prefix":"10.1111","volume":"22","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Centre for Epidemiological Studies and Clinical Trials Shanghai Key Laboratory of Hypertension The Shanghai Institute of Hypertension Department of Hypertension Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2010Yuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Centre for Epidemiological Studies and Clinical Trials Shanghai Key Laboratory of Hypertension The Shanghai Institute of Hypertension Department of Hypertension Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-1598","authenticated-orcid":false,"given":"Li\u2010Nong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Renmin Hospital Peking University Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-1524","authenticated-orcid":false,"given":"Ji\u2010Guang","family":"Wang","sequence":"additional","affiliation":[{"name":"Centre for Epidemiological Studies and Clinical Trials Shanghai Key Laboratory of Hypertension The Shanghai Institute of Hypertension Department of Hypertension Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the ATTEND investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032380"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.168118"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000994"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001106"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000194119.42722.21"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3024"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7160.703"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01003.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001286"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1006524"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S010"},{"key":"e_1_2_9_16_1","first-page":"182","article-title":"2018 Chinese guidelines for prevention and treatment of hypertension\u2010a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension","volume":"16","author":"Joint Committee for Guideline Revision","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"e_1_2_9_17_1","first-page":"1","article-title":"2016 Chinese guidelines for the management of dyslipidemia in adults","volume":"15","author":"Joint Committee for Guideline Revision","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2018.08.008"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7369.860"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61303-8"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000354417.70192.be"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.162446"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-7-200304010-00018"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.037"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/08037050701287703"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.13793","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jch.13793","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jch.13793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:19:22Z","timestamp":1694045962000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jch.13793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1111\/jch.13793"],"URL":"https:\/\/doi.org\/10.1111\/jch.13793","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"2019-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}